The treatment of chronic depression, Part 2: A double-blind, randomized trial of sertraline and imipramine

Journal of Clinical Psychiatry

Volumn 59, Issue 11, 1998, Pages 598-607

  Keller, Martin B ^a   Gelenberg, Alan J ^b   Hirschfeld, Robert M A ^c   Rush, A John ^d   Thase, Michael E ^e   Kocsis, James H ^f   Markowitz, John C ^f   Fawcett, Jan A ^g   Koran, Lorrin M ^h   Klein, Daniel N ⁱ   Russell, James M ^c   Kornstein, Susan G ^j   McCullough, James P ^j   Davis, Sonia M ^k   Harrison, Wilma M ^l  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ STONY BROOK UNIVERSITY   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k IQVIA   (United States)

^l Columbia Univ School of Medicine ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CHLORAL HYDRATE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; SERTRALINE; TEMAZEPAM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERHIDROSIS; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; VERTIGO; XEROSTOMIA;

EID: 0031789697     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n1107     Document Type: Article

References (45)

1. Keller MB, Shapiro RW. Double depression: superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry 1982; 139:438-442
2. Keller MB, Klerman GL, Lavori PW, et al. Treatment received by depressed patients. JAMA 1982;248:1848-1855
3. Wells RB, Stewart A, Burnam A, et al. The functioning and well being of depressed patients: results from the Medical Outcomes Study. JAMA 1989;262:914-919
4. Montgomery SA, Montgomery DB. Prophylactic treatment in recurrent unipolar depression. In: Montgomery SA, Rouillon F, eds. Long-Term Treatment of Depression. Chichester, England: John Wiley; 1992:53-80
5. Depression Guideline Panel, vols 1 and 2. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993
6. Thase ME, Sullivan LR. Relapse and recurrence of depression. Practical Ther CNS Drugs 1995;4:261-277
7. Howland RH. Pharmacotherapy of dysthymia: a review. J Clin Psychopharmacol 1991;11:83-92
8. Harrison W, Stewart JW. Pharmacotherapy of dysthymic disorder. In: Kocsis JH, Klein DN, eds. Diagnosis and Treatment of Chronic Depression. New York, NY: Guilford Press; 1995:124-125
9. Howland RH. Chronic depression. Hosp Community Psychiatry 1993;44: 633-639
10. Guelfi JD, Wiseman R. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression. Presented at the 8th European Congress of Neuropsychopharmacology; October 1995; Venice, Italy
11. Thase ME, Fava M, Halbreich U, et al. A placebo-controlled randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996;53:777-784
12. Greenberg PE, Stiglin LE, Finkelstein SN, et al. Economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-419
13. Guze SB, Robins C. Suicide in primary affective disorders. Br J Psychiatry 1970;117:437-438
14. Rush AJ, Koran LM, Keller MB, et al. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry 1998;59:589-597
15. Kocsis JH, Friedman RA, Markowitz JC, et al. Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch Gen Psychiatry 1996;53:769-774
16. Doogan DP, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992;160:217-222
17. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47: 1093-1099
18. Kocsis JH, Frances AJ, Voss C, et al. Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988;45:253-257
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
20. Magnus R, Preskorn S, Lane R. Minimum effective doses of SSRIs. Eur Neuropsychopharmacol 1996;6(suppl 3):121
21. Spitzer RL, Williams JBW, Gibbon M. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID I 4/1/87 Revision). New York, NY: Biometric Research, New York State Psychiatric Institute; 1987
22. Spitzer RL, Williams JBW, Gibbon M. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID-II 10/15/87 Revision). New York, NY: Biometric Research, New York State Psychiatric Institute; 1987
23. Montgomery SA, Asberg M. A new depression rating scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
24. Schneider K. Psychopathic Personalities. Springfield, Ill: Charles C Thompson; 1958
25. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987;44:540-548
26. Weissman MM, Boswell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976;33:1111-1115
27. Tarlov AR, Ware JE, Greenfield S, et al. Medical Outcomes Study: an application of methods for evaluating the results of medical care. JAMA 1989;262:907-913
28. Frank E, Prien R, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of response, remission, recovery, relapse and recurrence in major depression disorder. Arch Gen Psychiatry 1991;48: 851-855
29. Miller IW, Keitner G, Thase M, et al. The treatment of chronic depression, part 3: psychosocial functioning of chronically depressed patients before and after treatment with sertraline or imipramine. J Clin Psychiatry 1998;59:608-619
30. Keller MB, Baker LA, Russell CW. Classification and treatment of dysthymia. In: Dunner DL, ed. Current Psychiatric Therapy. New York, NY: Harcourt Brace Jovanovich; 1993:210-214
31. Keller MB, Sessa FM. Dysthymia: development and clinical course. In: Akiskal HS, Burton SW, eds. Dysthymic Disorder. London, England: Gaskell Publications; 1993
32. Klein DN, Taylor FB, Harding K, et al. Double depression and episodic major depression: demographic clinical, familial, personality and socioenvironmental characteristics and short-term outcome. Am J Psychiatry 1988;145:1226-1231
33. Coryell W, Endicott J, Keller MB. Outcome of patients with chronic affective disorder: a five-year follow-up. Am J Psychiatry 1990;147: 1627-1633
34. Shapiro RW, Keller MB. Initial 6-month follow-up of patients with major depressive disorder: a preliminary report from the NIMH collaborative study of the psychobiology of depression. J Affect Disord 1981;3:205-220
35. Keller MB. Undertreatment of major depression. Psychopharmacol Bull 1988;24:75-80
36. Pérez-Stable EJ, Miranda J, Munoz RF, et al. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med 1990;150: 1083-1088
37. Markowitz JC, Moran ME, Kocsis JH, et al. Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affect Disord 1992;24:63-71
38. Magruder KM, Norquist GS, Feil MB, et al. Who comes to a voluntary depression screening program? Am J Psychiatry 1995;152:1615-1622
39. Rush AJ, Gullion CM, Ruffwarg HP, et al. When do patients respond to tricyclic antidepressants [abstract]. Biol Psychiatry 1994;35:711-717
40. Harp JF, Frank E, Anderson B, et al. Time to remission in late life depression: analysis of effects of demographic, treatment and life events measures. Depression 1993;1:250-256
41. Schweizer E, Rickels K, Amsterdam JD, et al. What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry 1990;51:8-11
42. Quitkin FM, Harrison W, Stewart JM, et al. Response to phenelzine and imipramine in placebo non-responders with atypical depression. Arch Gen Psychiatry 1991;48:319-323
43. Stewart JW, McGrath PJ, Quitkin FM, et al. Chronic depression: response to placebo, imipramine, and phenelzine. J Clin Psychopharmacol 1993;13: 391-396
44. Khan A, Dager SR, Cohen S, et al. Chronicity of depressive episode in relation to antidepressant placebo response. Neuropsychopharmacol 1991;4: 125-130
45. Trivedi MH, Rush J. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications. Neuropsychopharmacology 1994;11:33-43